Insider Trading Activity For Cell MedX Corp (NASDAQ:CMXC)
Richard Jeffs , Major Shareholder of Cell MedX Corp (NASDAQ:CMXC) reportedly Bought 5,000 shares of the company’s stock at an average price of 0.35 for a total transaction amount of $1,750.00 SEC Form
Analyst Ratings For Cell MedX Corp (NASDAQ:CMXC)
These are No ratings tracked in the last 12 months. .
The current consensus rating for Cell MedX Corp (NASDAQ:CMXC) is N/A (Score: NaN) with a consensus target price of N/A
About Cell MedX Corp (NASDAQ:CMXC)
Cell MedX Corp. is a development-stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases, such as diabetes, by developing technologies to help manage the illness and related complications. The Company, through its subsidiary, Avyonce Cosmedics Inc. (Avyonce), is engaged in reselling and marketing spa technology and equipment to the beauty and wellness industry. Avyonce is involved in carrying out observational studies using eBalance Technology. The eBalance Technology is used for the use of micro currents for the treatment of diabetes and related ailments. Avyonce also provides continuing education to the estheticians and healthcare professionals in the field of medical aesthetics. The Company is engaged in developing a family of devices based on the eBalance Technology.
Recent Trading Activity for Cell MedX Corp (NASDAQ:CMXC)
Shares of Cell MedX Corp closed the previous trading session at 0.375 up +0.020 5.61% with 1,588 shares trading hands.
The post Insider Trading Activity Cell MedX Corp (NASDAQ:CMXC) – Major Shareholder Bought 5,000 shares of Stock appeared first on Market Exclusive.
© Market Exclusive 2017, source Market Exclusive